HomeNewsWorldFirst major cruise line MSC Grandiosa set to depart Genoa for Mediterranean tour

First major cruise line MSC Grandiosa set to depart Genoa for Mediterranean tour

The departure of the MSC Grandiosa from the northwestern port city at 1930 local time (1730 GMT) represents a high-stakes test for the global sector in the key Mediterranean market and beyond.

August 16, 2020 / 15:30 IST
Story continues below Advertisement

The first major cruise ship to set sail in the Mediterranean was poised to depart from Genoa on Sunday, as Italy's struggling travel industry hopes to regain ground after a bruising coronavirus hiatus.

The departure of the MSC Grandiosa from the northwestern port city at 1930 local time (1730 GMT) represents a high-stakes test for the global sector in the key Mediterranean market and beyond.

Story continues below Advertisement

The international cruise industry has been battered not only by the ongoing health crisis which in March forced the worldwide grounding of its ships, but accusations of a botched handling of the epidemic in its early stages.

Cruise lines are hoping that new, tighter protocols will allow them to control the still-lingering threat of coronavirus aboard its ships while still offering travellers a cruise experience that does not disappoint.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show